INS and metabolic disease: In the context of metabolic disorders, numerous preclinical and clinical studies indicate that CGA improves insulin sensitivity, regulates blood glucose levels, lowers blood pressure, and positively affects the lipid profile by reducing LDL cholesterol and triglyceride levels while increasing HDL cholesterol [87,88,89,90,91,92,93,183].